Nestlé Health Science has acquired a stake in Accera to support the ongoing trials and rollout of the firm’s key brand, Axona, a medical food intended for the clinical dietary management of mild to moderate Alzheimer’s disease, already on the market in the United States.
IFT Daily News
Leave a Comment